Friday, April 17, 2026

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

Seoul Pushes Back on Tariff Violation Claims as Nuclear Deal Revision Talks Loom

South Korea's Foreign Minister Cho Hyun plans talks with U.S. officials on tariffs, nuclear agreement, and regional peace during his visit.

South Korea’s North Korean Human Rights Policy Needs Bipartisan Consistency

A visit to Iran reshaped perceptions, highlighting shared humanity and the complexities of North Korean human rights discussions in South Korea.

Tag: Virginia International Tattoo

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

No posts to display

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.